Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 24, 2023

SELL
$118.5 - $160.53 $427,785 - $579,513
-3,610 Reduced 98.63%
50 $6.08 Million
Q1 2023

May 12, 2023

SELL
$135.66 - $197.02 $143,799 - $208,841
-1,060 Reduced 22.46%
3,660 $562 Million
Q4 2022

Feb 13, 2023

BUY
$118.38 - $210.04 $558,753 - $991,388
4,720 New
4,720 $848 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $12.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Mrp Capital Investments, LLC Portfolio

Follow Mrp Capital Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mrp Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mrp Capital Investments, LLC with notifications on news.